Paclitaxel topical - US Biotest

Drug Profile

Paclitaxel topical - US Biotest

Alternative Names: SOR 007

Latest Information Update: 07 Feb 2017

Price : $50

At a glance

  • Originator DFB Soria
  • Developer DFB Soria; US Biotest Inc
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Angiogenesis inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Plaque psoriasis

Most Recent Events

  • 07 Feb 2017 Chemical structure information added
  • 01 Aug 2016 Phase-I clinical trials in Plaque psoriasis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top